共 43 条
- [31] A Randomized, Double-blind, Placebo-controlled, Repeat Injection, 52-Week Study to Evaluate the Efficacy and Safety of an Intra-articular Injection (IAI) of CNTX-4975-05 (CNTX) in Subjects with Chronic, Moderate-to-severe Osteoarthritis Knee Pain (MSOAKP) - Study 304 ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 630 - 632
- [34] The presence of concomitant intra-articular injuries and bone bruise does not affect pre-operative knee pain and symptoms in patients undergoing anterior cruciate ligament reconstruction Knee Surgery, Sports Traumatology, Arthroscopy, 2019, 27 : 893 - 897
- [38] An Investigator-Initiated, Prospective, Single-Center, Open-Label Clinical Study to Evaluate Safety and Performance of Intra-Articular Hyaluronic Acid (IA-HA) (Biovisc Ortho) in Patients with Osteoarthritis (OA) of the Knee CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2021, 13 : 73 - 82
- [39] Synovial and systemic pharmacokinetics (PK) of triamcinolone acetonide (TA) following intra-articular (IA) injection of an extended-release microsphere-based formulation (FX006) or standard crystalline suspension in patients with knee osteoarthritis (OA) OSTEOARTHRITIS AND CARTILAGE, 2018, 26 (01) : 34 - 42
- [40] A Randomized, Double-Blind, Dose Ranging Study Comparing FX006, An Intra-Articular (IA) Sustained-Release Formulation Of Triamcinolone Acetonide (TCA), To An Approved Injectable Suspension Of TCA In Patients With Osteoarthritis (OA) Of The Knee ARTHRITIS AND RHEUMATISM, 2013, 65 : S1138 - S1138